Objectives: Drug repurposing (DR), a promising tool to accelerate drug discovery, has increasingly drawn scientists’ attention. This study aims to explore the landscape of DR through visualization analysis on DR-related publications. Methods: Data were collected from the Web of Science Core Collection between 2000 and 2018. Data was analyzed in terms of publication outputs, journals, countries, institutions, authors, co-authorship, co-citation, research hotspots and evolution trends through VOSviewer and CiteSpace. Results: From 2000 to 2018, we can see a continuous growth in the number of DR related publications. PLoS One published the highest number of publications, followed by Scientific Reports, Oncotarget and Antimicrobial Agents and Chemotherapy. The United States (USA) was the most leading country in DR research, in terms of publications, institutions, co-authorship and co-citation. Talevi A (Argentina) was the most productive authors and Ashburn TT (USA) contributed the most cited articles in this area. The hotspots of DR research were cancer, drug discovery, apoptosis, polypharmacology and virtual screening, whereas the emerging trends of DR were connectivity map, database, pathway and apoptosis. Conclusions: This study might help beginners to quickly understand the cutting-edge knowledge, mainstream research directions, hot spots and research trends of this research field.
| Published in | Advances in Bioscience and Bioengineering (Volume 9, Issue 2) |
| DOI | 10.11648/j.abb.20210902.14 |
| Page(s) | 39-47 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Drug Repurposing, Bibliometric Analysis, VOSviewer, CiteSpace, Drug Discovery
| [1] | Simsek M, Meijer B, van Bodegraven AA, de Boer NKH, Mulder CJJ. Finding hidden treasures in old drugs: the challenges and importance of licensing generics. Drug Discov Today 2018; 23: 17-21. |
| [2] | Jin G, Wong ST. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines. Drug Discov Today 2014; 19: 637-644. |
| [3] | Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004; 3: 673-683. |
| [4] | Baker NC, Ekins S, Williams AJ, Tropsha A. A bibliometric review of drug repurposing. Drug Discov Today 2018;23:661-672. |
| [5] | Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-1404. |
| [6] | Hou D, Bi X, Mao Z, Fan Y, Hu X, Li X. Biomaterials research of China from 2013 to 2017 based on bibliometrics and visualization analysis. PeerJ 2019; 7: e6859. |
| [7] | Liu H, Yu Z, Chen C, Hong R, Jin K, Yang C. Visualization and bibliometric analysis of research trends on human fatigue assessment. J Med Syst 2018; 42: 179. |
| [8] | Popkirov S, Jungilligens J, Schlegel U, Wellmer J. Research on dissociative seizures: a bibliometric analysis and visualization of the scientific landscape. Epilepsy Behav 2018; 83: 162-167. |
| [9] | Zou L, Sun L. Global diabetic kidney disease research from 2000 to 2017. Medicine 2019; 98: e14394. |
| [10] | Zou X, Yue WL, Vu HL. Visualization and analysis of mapping knowledge domain of road safety studies. Accid Anal Prev 2018; 118: 131-145. |
| [11] | Zyoud SH, Smale S, Waring WS, Sweileh WM, Al-Jabi SW. Global research trends in microbiome-gut-brain axis during 2009–2018: a bibliometric and visualized study. BMC Gastroenterol 2019; 19: 158. |
| [12] | Tahamtan I, Safipour Afshar A, Ahamdzadeh K. Factors affecting number of citations: a comprehensive review of the literature. Scientometrics 2016; 107: 1195-1225. |
| [13] | Osareh F. Bibliometncs, citation analysis and co-citation analysis: a review of literature I. Libri. 1996; 49: 149-158. |
| [14] | Chen C. CiteSpace II:detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol 2006; 57: 359-377. |
| [15] | Girvan M, Newman MEJ. Community structure in social and biological networks. Proc Natl Acad Sci USA 2002; 99: 7821-7826. |
| [16] | Parvathaneni V, Kulkarni NS, Muth A, Gupta V. Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discov Today 2019; 24: 2076-2085. |
| [17] | Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, et al. Predicting new molecular targets for known drugs. Nature 2009; 462: 175-181. |
| [18] | Polamreddy P, Gattu N. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions. Drug Discov Today 2019; 24:789-795. |
| [19] | Reyes-Gonzalez L, Gonzalez-Brambila CN, Veloso F. Using co-authorship and citation analysis to identify research groups: a new way to assess performance. Scientometrics 2016; 108: 1171-1191. |
| [20] | Small H. Co-citation in the scientific literature: a new measure of the relationship between two documents. J Am Soc Inf Sci 1973; 24: 265-269. |
| [21] | Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 2019; 18: 41-58. |
| [22] | Reddy AS, Zhang S. Polypharmacology: drug discovery for the future. Expert Rev Clin Pharmacol 2013; 6: 41-47. |
| [23] | Sawada R, Iwata H, Mizutani S, Yamanishi Y. Target-based drug repositioning using large-scale chemical-protein interactome data. J Chem Inf Model 2015; 55: 2717-2730. |
| [24] | Hafeez BB, Ganju A, Sikander M, Kashyap VK, Hafeez ZB, Chauhan N, et al. Ormeloxifene suppresses prostate tumor growth and metastatic phenotypes via inhibition of oncogenic beta-catenin signaling and EMT progression. Mol Cancer Ther 2017; 16: 2267-2280. |
| [25] | Iorio F, Saez-Rodriguez J, di Bernardo D. Network based elucidation of drug response: from modulators to targets. BMC Syst Biol 2013; 7: 139. |
| [26] | Wu H, Huang J, Zhong Y, Huang Q. DrugSig: a resource for computational drug repositioning utilizing gene expression signatures. PLoS One 2017; 12: e177743. |
| [27] | Martinez MD, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 2013; 341: 84-87. |
| [28] | Zheng W, Thorne N, McKew JC. Phenotypic screens as a renewed approach for drug discovery. Drug Discov Today 2013; 18: 1067-1073. |
APA Style
Wei Li, Li Wan. (2021). Global Drug Repurposing Research from 2000 to 2018: A Bibliometric Analysis. Advances in Bioscience and Bioengineering, 9(2), 39-47. https://doi.org/10.11648/j.abb.20210902.14
ACS Style
Wei Li; Li Wan. Global Drug Repurposing Research from 2000 to 2018: A Bibliometric Analysis. Adv. BioSci. Bioeng. 2021, 9(2), 39-47. doi: 10.11648/j.abb.20210902.14
AMA Style
Wei Li, Li Wan. Global Drug Repurposing Research from 2000 to 2018: A Bibliometric Analysis. Adv BioSci Bioeng. 2021;9(2):39-47. doi: 10.11648/j.abb.20210902.14
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.abb.20210902.14,
author = {Wei Li and Li Wan},
title = {Global Drug Repurposing Research from 2000 to 2018: A Bibliometric Analysis},
journal = {Advances in Bioscience and Bioengineering},
volume = {9},
number = {2},
pages = {39-47},
doi = {10.11648/j.abb.20210902.14},
url = {https://doi.org/10.11648/j.abb.20210902.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.abb.20210902.14},
abstract = {Objectives: Drug repurposing (DR), a promising tool to accelerate drug discovery, has increasingly drawn scientists’ attention. This study aims to explore the landscape of DR through visualization analysis on DR-related publications. Methods: Data were collected from the Web of Science Core Collection between 2000 and 2018. Data was analyzed in terms of publication outputs, journals, countries, institutions, authors, co-authorship, co-citation, research hotspots and evolution trends through VOSviewer and CiteSpace. Results: From 2000 to 2018, we can see a continuous growth in the number of DR related publications. PLoS One published the highest number of publications, followed by Scientific Reports, Oncotarget and Antimicrobial Agents and Chemotherapy. The United States (USA) was the most leading country in DR research, in terms of publications, institutions, co-authorship and co-citation. Talevi A (Argentina) was the most productive authors and Ashburn TT (USA) contributed the most cited articles in this area. The hotspots of DR research were cancer, drug discovery, apoptosis, polypharmacology and virtual screening, whereas the emerging trends of DR were connectivity map, database, pathway and apoptosis. Conclusions: This study might help beginners to quickly understand the cutting-edge knowledge, mainstream research directions, hot spots and research trends of this research field.},
year = {2021}
}
TY - JOUR T1 - Global Drug Repurposing Research from 2000 to 2018: A Bibliometric Analysis AU - Wei Li AU - Li Wan Y1 - 2021/06/03 PY - 2021 N1 - https://doi.org/10.11648/j.abb.20210902.14 DO - 10.11648/j.abb.20210902.14 T2 - Advances in Bioscience and Bioengineering JF - Advances in Bioscience and Bioengineering JO - Advances in Bioscience and Bioengineering SP - 39 EP - 47 PB - Science Publishing Group SN - 2330-4162 UR - https://doi.org/10.11648/j.abb.20210902.14 AB - Objectives: Drug repurposing (DR), a promising tool to accelerate drug discovery, has increasingly drawn scientists’ attention. This study aims to explore the landscape of DR through visualization analysis on DR-related publications. Methods: Data were collected from the Web of Science Core Collection between 2000 and 2018. Data was analyzed in terms of publication outputs, journals, countries, institutions, authors, co-authorship, co-citation, research hotspots and evolution trends through VOSviewer and CiteSpace. Results: From 2000 to 2018, we can see a continuous growth in the number of DR related publications. PLoS One published the highest number of publications, followed by Scientific Reports, Oncotarget and Antimicrobial Agents and Chemotherapy. The United States (USA) was the most leading country in DR research, in terms of publications, institutions, co-authorship and co-citation. Talevi A (Argentina) was the most productive authors and Ashburn TT (USA) contributed the most cited articles in this area. The hotspots of DR research were cancer, drug discovery, apoptosis, polypharmacology and virtual screening, whereas the emerging trends of DR were connectivity map, database, pathway and apoptosis. Conclusions: This study might help beginners to quickly understand the cutting-edge knowledge, mainstream research directions, hot spots and research trends of this research field. VL - 9 IS - 2 ER -
Email: